Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
J Clin Pediatr Dent ; 45(4): 239-246, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-34534305

ABSTRACT

OBJECTIVE: Regarding the 2011 census in Hungary, the number of children with movement deficiences can be around 7,000. These children with special health care needs are considered to be a vulnerable group even from a dental point of view. In our dental program, we gain comprehensive information about patients' oral health, health behavior, and monitor dental care. STUDY DESIGN: A total of 199 children went through a full pediatric dental examination, children with cerebral palsy were categorized into five different levels (GMFCS) and children without motor disfunction into two groups. We analyzed the df-t and DMF-T values. Oral hygiene routine, dental care, gingivitis, demographic characteristics, nutritional habits odds ratio to df-t and DMF-T were surveyed. RESULTS: The mean df-t and DMF-T was 1.87 and 1.15 out of a total of 199, and the group that scored worse was the GMFCS II. The mean RI (restorative index) was 18.12% and 27% for decidous and permanent teeth, respectively. The prevalence of gingivitis was 66.7%. CONCLUSION: The results of our research point to the fact that children with cerebral palsy have difficulties in developing and maintaining proper oral health due to their disadvantages and therefore require special care and attention.


Subject(s)
Cerebral Palsy , Dental Caries , Cerebral Palsy/complications , Cerebral Palsy/epidemiology , Child , DMF Index , Dental Care , Dental Caries/epidemiology , Habits , Humans , Oral Health , Prevalence
3.
Orthod Craniofac Res ; 19(4): 198-208, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27647720

ABSTRACT

OBJECTIVES: To test the following two hypotheses: 1) different types of retainers result in distinct levels of biomarkers in gingival crevicular fluid (GCF) and 2) the retainer bonded to all mandibular anterior teeth induces more detrimental outcomes to the periodontium. SETTING AND SAMPLE POPULATION: The Department of Orthodontics at the University of Florida. The population consisted of individuals in the retention phase of orthodontic treatment. MATERIAL AND METHODS: This was a cross-sectional study that enrolled 36 individuals. Subjects in group 1 had retainers bonded to the mandibular canines only. Group 2 consisted of individuals having retainers bonded to all mandibular anterior teeth. Group 3 included patients using mandibular removable retainers. After clinical examination, GCF was collected from the mandibular incisor and biomarker levels were compared between the groups. RESULTS: Plaque accumulation and gingivitis differed significantly among groups, with the highest median values in group 2 subjects. Pairwise comparison of the groups with respect to gingivitis showed significant differences between groups 1 and 2. Significant differences among groups were detected for RANKL, OPG, OPN, M-CSF, MMP-3, and MMP-9. The ratio RANKL/OPG was significantly higher in group 2 subjects, with pairwise comparisons indicating that groups 1 and 2 differed from group 3. CONCLUSION: An association was found between orthodontic retention groups and GCF biomarker levels, which should be further explored in longitudinal studies. The presence of retainers bonded to all anterior teeth seems to increase plaque accumulation and gingivitis.


Subject(s)
Biomarkers/chemistry , Dental Bonding/adverse effects , Dental Bonding/methods , Dental Plaque/etiology , Gingival Crevicular Fluid/chemistry , Gingival Recession/etiology , Gingivitis/etiology , Incisor/pathology , Incisor/physiopathology , Orthodontic Retainers/adverse effects , Adolescent , Adult , Cross-Sectional Studies , Cuspid , Dental Plaque Index , Female , Humans , Interleukin 1 Receptor Antagonist Protein/chemistry , Interleukin-1beta/chemistry , Interleukin-6/chemistry , Interleukin-8/chemistry , Macrophage Colony-Stimulating Factor/chemistry , Male , Mandible , Matrix Metalloproteinase 3/chemistry , Matrix Metalloproteinase 9/chemistry , Middle Aged , Orthodontic Appliance Design , Osteopontin/chemistry , Osteoprotegerin/chemistry , Periodontal Index , RANK Ligand/chemistry
4.
J Clin Oncol ; 22(10): 1864-71, 2004 May 15.
Article in English | MEDLINE | ID: mdl-15143078

ABSTRACT

PURPOSE: To assess the cardiac status of the long-term survivors and to estimate the incidence and the features of subclinical cardiotoxicity induced after conventional treatment with doxorubicin for non-Hodgkin's lymphoma or Hodgkin's lymphoma. PATIENTS AND METHODS: We analyzed a group of patients who previously received doxorubicin-based chemotherapy for lymphoma. Echocardiograms were performed at least 5 years after therapy with anthracyclines. Clinical cardiomyopathy was defined by the presence of clinical signs of congestive heart failure (CHF). Subclinical cardiomyopathy was defined by decrease of left ventricular fractional shortening (FS) without clinical signs of CHF. Cumulative dose of doxorubicin, male sex, older age, relapse, radiotherapy (mediastinal or total-body irradiation), autologous stem-cell transplantation, high-dose cyclophosphamide, and cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia, familial history of cardiac disease, being overweight, and smoking history) were evaluated as potential risk factors for the development of cardiac dysfunction. RESULTS: Of 141 assessable patients (median age, 54 years; median cumulative dose of doxorubicin, 300 mg/m(2)), only one developed CHF. Criteria of subclinical cardiomyopathy were found in 39 patients. In multivariate analysis, factors that contributed to decreased FS were male sex (P <.01), older age (P <.01), higher cumulative dose of doxorubicin or association with another anthracycline (P =.04), radiotherapy (P =.04), and being overweight (P =.04). CONCLUSION: Cardiac abnormalities can occur in patients treated with doxorubicin for lymphoma in the absence of CHF, even in patients who received moderate anthracycline doses. Male sex, older age, higher dose of doxorubicin, radiotherapy, and being overweight were risk factors for the development of cardiomyopathy.


Subject(s)
Antibiotics, Antineoplastic/adverse effects , Cardiomyopathies/epidemiology , Doxorubicin/adverse effects , Lymphoma/drug therapy , Adult , Aged , Aged, 80 and over , Cardiomyopathies/chemically induced , Electrocardiography , Female , France/epidemiology , Humans , Male , Middle Aged , Risk Factors
5.
Bone Marrow Transplant ; 33(9): 921-3, 2004 May.
Article in English | MEDLINE | ID: mdl-15034544

ABSTRACT

Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antigens, CD20/chemistry , Antineoplastic Agents/pharmacology , Lymphoma, Non-Hodgkin/therapy , Neutropenia/etiology , Aged , Antibodies, Monoclonal, Murine-Derived , Female , Granulocyte Colony-Stimulating Factor/metabolism , Humans , Male , Middle Aged , Neutrophils/metabolism , Rituximab , Stem Cell Transplantation , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...